Development and Validation of an Interpretable Machine Learning Model for Predicting Venous Thromboembolism(VTE)in Intensive Care Unit (ICU) Patients
1 other identifier
observational
12,061
1 country
1
Brief Summary
Venous thromboembolism remains a leading cause of preventable mortality in intensive care unit (ICU) patients. Existing risk-stratification tools were developed in general medical populations and lack ICU-specific predictors. This study was to develop and validate an interpretable machine learning (ML) model to predict VTE in ICU patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedMay 19, 2026
January 1, 2022
4 years
May 12, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
validate an interpretable machine learning (ML) model to predict VTE in ICU patients
the first day after the patients leaf ICU
Interventions
no intervention
Eligibility Criteria
Patients admitted to ICU were included in the study cohort from January 2022 to October 2025. Inclusion criteria were: (1) age ≥18 years; (2) ICU length of stay ≥48 hours; (3) only the first ICU admission per patient was retained. Exclusion criteria were: (1) VTE diagnosed prior to ICU admission; (2) VTE diagnosed within 24 hours of ICU admission; (3) \>20% missing values in key variables. The final cohort comprised 12,061 patients, of whom 587 (4.9%) developed VTE during ICU hospitalization.
You may qualify if:
- age ≥18 years;
- ICU length of stay ≥48 hour
- the first ICU admission
You may not qualify if:
- VTE diagnosed prior to ICU admission
- VTE diagnosed within 24 hours of ICU admission
- \>20% missing values in key variables
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- vice president
Study Record Dates
First Submitted
May 12, 2026
First Posted
May 19, 2026
Study Start
January 1, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 19, 2026
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share